Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2017-03-13 2017-03-13
Drug Identification Number 00872520 00872520
Brand name HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION
Common or Proper name HYDROCORTISONE SODIUM SUCCINATE HYDROCORTISONE SODIUM SUCCINATE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients HYDROCORTISONE HYDROCORTISONE
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 10
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-29 2016-02-29
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments